Back to Search
Start Over
Gain Therapeutics to Present Positive Preclinical Data on its GBA1 Program at the AD/PD 2023 Meeting
- Source :
- GlobeNewswire. March 29, 2023
- Publication Year :
- 2023
-
Abstract
- BETHESDA, Md., March 29, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) ('Gain', or the 'Company'), a biotechnology company leading the discovery and development of allosteric small molecule therapies, [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- GlobeNewswire
- Publication Type :
- News
- Accession number :
- edsgcl.743429006